Minna Björkqvist

Low tumor necrosis factor‐α levels predict symptom reduction during electroconvulsive therapy in major depressive disorder

O. Kampman, E. Leinonen, E. Moilanen, 2018, Brain and behavior.

One-Year Follow-Up After Discontinuing Maintenance Electroconvulsive Therapy

O. Kampman, E. Leinonen, H. Alanen, 2012, The journal of ECT.

Changes in interleukin‐6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression

O. Kampman, E. Leinonen, J. Peltola, 2017, Acta psychiatrica Scandinavica.

Effect of electroconvulsive therapy on brain‐derived neurotrophic factor levels in patients with major depressive disorder

O. Kampman, E. Leinonen, E. Moilanen, 2018, Brain and behavior.

Effects of S-Ketamine as an Anesthetic Adjuvant to Propofol on Treatment Response to Electroconvulsive Therapy in Treatment-Resistant Depression: A Randomized Pilot Study

A. Yli-Hankala, O. Kampman, E. Leinonen, 2013, The journal of ECT.

Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder

O. Kampman, E. Leinonen, E. Moilanen, 2021, Brain and behavior.